Safer use of short-acting beta2-agonists: perceiving and responding to risk-a qualitative study
Eliza J McEwin1, Lorraine Smith2, Brett Toelle3
1School of Pharmacy Building A15 Science Road and the Charles Perkins Centre Building D17 John Hopkins Drive, University of Sydney, Camperdown, Australia.
Methods:
People with asthma who overuse SABAs were enrolled into the study through community pharmacist invitation. Semi-structured interviews were completed by telephone or via Zoom. The recordings were transcribed and thematically analyzed using inductive and deductive approaches.
Results:
Between September 2021 and May 2022, 21 people were interviewed. Data analyses yielded six themes. Three themes related to risk perception including risks related to asthma, medicines, and other factors such as environmental triggers. Three themes related to how people responded to their perceived risk. These included actions taken by some to reduce risk while others chose not to act to reduce risk, despite knowing how to, suggesting a lack of self-efficacy.
Conclusions:
This is the first study of its kind in a group of Australians who have asthma, a common, as yet incurable, often lifelong chronic health condition. Our interviews yielded rich and sometimes surprising insights into the complexity and number of factors contributing to how people perceive and respond to risks associated with their asthma and with the medicines that they take to manage it.
More Related Videos
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:28Antihypertensive Drugs: Types of β-Blockers
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: